BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 38654216)

  • 1. CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway.
    Lyu F; Huang S; Yan Z; He Q; Liu C; Cheng L; Cong Y; Chen K; Song Y; Xing Y
    Cell Signal; 2024 Jul; 119():111164. PubMed ID: 38583745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma.
    Chi H; Peng G; Yang J; Zhang J; Song G; Xie X; Strohmer DF; Lai G; Zhao S; Wang R; Yang F; Tian G
    Front Endocrinol (Lausanne); 2022; 13():1056310. PubMed ID: 36568076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.
    Marino-Enriquez A; Novotny JP; Gulhan DC; Klooster I; Tran AV; Kasbo M; Lundberg MZ; Ou WB; Tao DL; Pilco-Janeta DF; Mao VY; Zenke FT; Leeper BA; Gokhale PC; Cowley GS; Baker LH; Ballman KV; Root DE; Albers J; Park PJ; George S; Fletcher JA
    Clin Cancer Res; 2023 Dec; 29(24):5128-5139. PubMed ID: 37773632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells: balancing resistance and sensitivity to DNA damage.
    Liu JC; Lerou PH; Lahav G
    Trends Cell Biol; 2014 May; 24(5):268-74. PubMed ID: 24721782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma.
    Chi H; Peng G; Yang J; Zhang J; Song G; Xie X; Strohmer DF; Lai G; Zhao S; Wang R; Yang F; Tian G
    Front Endocrinol (Lausanne); 2024; 15():1421538. PubMed ID: 38784067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
    Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
    BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonic Stem Cells Modulate the Cancer-Permissive Microenvironment of Human Uveal Melanoma.
    Liu J; Huang Z; Yang L; Wang X; Wang S; Li C; Liu Y; Cheng Y; Wang B; Sang X; He X; Wang C; Liu T; Liu C; Jin L; Liu C; Zhang X; Wang L; Wang Z
    Theranostics; 2019; 9(16):4764-4778. PubMed ID: 31367256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
    Zhan Z; Lin K; Wang T
    BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma.
    Kim YJ; Park SJ; Maeng KJ; Lee SC; Lee CS
    Sci Rep; 2019 Dec; 9(1):19235. PubMed ID: 31848373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
    Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
    J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and Functional Analysis of
    Mei S; Li Y; Kang X
    Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing.
    Lopacinska-Joergensen J; Oliveira DVNP; Poulsen TS; Hoegdall CK; Hoegdall EV
    Anticancer Res; 2023 May; 43(5):1891-1900. PubMed ID: 37097678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting DNA damage response pathways in cancer.
    Groelly FJ; Fawkes M; Dagg RA; Blackford AN; Tarsounas M
    Nat Rev Cancer; 2023 Feb; 23(2):78-94. PubMed ID: 36471053
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.